pumabiosecuritieslitigation.com Open in urlscan Pro
172.67.162.223  Public Scan

Form analysis
0 forms found in the DOM

Text Content

Puma Biotechnology Securities Litigation

HomeCase DocumentsFrequently Asked QuestionsContact UsFile Claim


WELCOME TO THE PUMA BIOTECHNOLOGY SECURITIES LITIGATION WEBSITE

UPDATE 1/11/22: A settlement has been preliminarily approved in the
above-captioned action. The Court-approved notice of the settlement can be
viewed on the Case Documents tab or by clicking here. You can identify if your
claim has been validated and the amount of your damages and prejudgment interest
by clicking here to view the validated claims sorted by claim number, or by
clicking here to view the validated claims sorted by beneficial owner. If you
have submitted a validated claim, you do not need to do anything in order to
receive your share of the settlement.

The deadline for any validated claimant to file an objection to the proposed
settlement, including attorneys’ fees and expenses, is March 21, 2022.  For
instructions on how to file an objection, click here.



In the case of HsingChing Hsu v. Puma Biotechnology, Inc., et al., No.
8:15-cv-00865, a two week trial began on January 15, 2019 in the United States
District Court for the Central District of California, Southern Division. On
February 4, 2019, the jury returned a verdict.

The jury found that defendants Puma and Alan H. Auerbach violated the federal
securities laws by making false and misleading statements about the efficacy of
Puma’s drug, neratinib, in a clinical trial and that defendants did so in
knowing violation of sections 10(b) and 20(a) of the Securities Exchange Act of
1934. As a result of this fraudulent conduct, the jury determined that Puma’s
stock price was artificially inflated by $4.50 per share between July 22, 2014
and May 13, 2015. You can find a copy of the jury verdict, and more information
about the trial and claims process under Case Documents.

The jury verdict will result in the payment of damages, minus certain deductions
described below, to eligible Class Members who file a timely and valid Proof of
Claim form (submitted online or by mail) and whose claims are approved. Class
Members whose claims are approved will be entitled to receive all of their
damages, plus interest, less their proportionate share of any fees and expenses
awarded by the Court.

YOU MUST HAVE ALREADY FILED A CLAIM FORM (COURT-ORDERED DEADLINE WAS JANUARY 28,
2020) TO COLLECT ANY DAMAGES YOU SUFFERED.




ADDITIONAL INFORMATION

Although the information on this website is intended to assist you, it does not
replace the information contained in the Notice of Verdict in Favor of Plaintfff
Class and Against Puma Biotechnology, Inc. and Alan H. Auerbach ("Notice of
Verdict")  which can be found and downloaded on the Case Documents page of this
website. We recommend that you read the Notice and other relevant case
documents carefully.  You may also wish to read the answers to Frequently Asked
Questions provided on this website. If you have not received a postcard notice
and would like to confirm that you are on the mailing list for further notice
mailings in this matter, please contact the Notice Administrator and request
that a postcard notice be sent to you at your current mailing address.




IMPORTANT DATES AND DEADLINES

File an Objection to the Settlement  March 21, 2022 Final Approval Hearing April
11, 2022

Gilardi & Co. LLC.    Copyright © 2024   Privacy Policy